Researchers at the National Eye Institute have developed the first patient-derived stem cell model for studying eye conditions related to oculocutaneous albinism (OCA).
Clearside Biomedical, Inc. , a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that multiple presentations were given at the Retina Society 54 th Annual Scientific Meeting which took place September 29 October 2, 2021 in Chicago, IL. “These presentations demonstrate the targeted and .
In Advanced Glaucoma, Trabeculectomy Lowers IOP More Than Medication medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Scientists restore partial sight in blind man using optogenetic therapy
Updated:
Updated:
May 25, 2021 12:58 IST
During the tests, the patient was able to locate and touch a notebook on a table in front of him 92% of the time while wearing the goggles. Without them, he was unable to perform any visual task.
Share Article
AAA
Experimental setup. Behavioral responses and brain activity were simultaneously recorded during the visual test. Credit: Sahel, JA., Boulanger-Scemama, E., Pagot, C. et al. Partial recovery of visual function in a blind patient after optogenetic therapy. Nat Med (2021). https://doi.org/10.1038/s41591-021-01351-4
During the tests, the patient was able to locate and touch a notebook on a table in front of him 92% of the time while wearing the goggles. Without them, he was unable to perform any visual task.